Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagula- tion surveys. Thromb Haemost. 2010;104(4):837-844. 51. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for the management of hep- arin therapy. Arch Intern Med. 1991;151(2):333-337. 52. Prandoni P, Carnovali M, Marchiori A; Galilei Investigators. Subcutaneous adjusted-dose unfractionated heparin vs xed- dose low-molecular-weight heparin in the initial treatment of venous thromboembolism. Arch Intern Med. 2004;164(10): 1077-1083. 53. Braunwald E, Antman E, Beasley J, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2000;36(3):970-1062. 54. Ryan T, Antman E, Brooks N, et al. 1999 update: ACC/ AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 1999;34(3): 890-911. 55. Levine M, Hirsh J, Kelton J. Heparin-induced bleeding. In: Land DA, Lindahl U, eds. Heparin: Chemical and Biological Properties, Clinical Applications. London, England: Edward Arnold; 1989:517-532. 56. Morabia A. Heparin doses and major bleedings. Lancet. 1986;1(8492):1278-1279. 57. Antman EM. the TIMI 9A Investigators. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial. Circulation. 1994;90(4):1624-1630. 58. Antman EM. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation. 1996;94(5):911-921. 59. GUSTO IIA Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Circulation. 1994;90(4):1631-1637. 60. GUSTO IIB Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. 